Erhöhtes COVID-19-Risiko für Frauen mit PCO-Syndrom

Bullerdiek J (2020) COVID-19 and blood groups—there is an elephant in the room, but who cares? Do we need additional rules for preprints? [version 1; peer review: 2 approved. F1000Res 9:1139. https://doi.org/10.12688/f1000research.26333.1 Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS (2020) Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med 18:220. https://doi.org/10.1186/s12916-020-01697-5 Subramanian A, Astha AA, Adderley NJ, Okoth K, Toulis KA, Gokhale K, Sainsbury C, O’Reilly MW, Arlt W, Nirantharakumar K (2021) Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol 184:637–645. https://doi.org/10.1530/EJE-20-1163